This paper deals with the problem of continuous lyophilization of pharmaceutical products, focusing on those concepts that are of greatest interest and most likely to be successful once applied in industrial practice. Also, it discusses all those factors that slow down the transition from batch to continuous in the pharmaceutical industry, and what actions may accelerate this transformation.
Continuous manufacturing of lyophilized products: Why and how to make it happen / Pisano, R.. - In: AMERICAN PHARMACEUTICAL REVIEW. - ISSN 1099-8012. - STAMPA. - 23:3(2020), pp. 1-4.
Continuous manufacturing of lyophilized products: Why and how to make it happen
Pisano R.
2020
Abstract
This paper deals with the problem of continuous lyophilization of pharmaceutical products, focusing on those concepts that are of greatest interest and most likely to be successful once applied in industrial practice. Also, it discusses all those factors that slow down the transition from batch to continuous in the pharmaceutical industry, and what actions may accelerate this transformation.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
a-2020_APR_23(3)_1-4.pdf
accesso riservato
Tipologia:
2a Post-print versione editoriale / Version of Record
Licenza:
Non Pubblico - Accesso privato/ristretto
Dimensione
1.01 MB
Formato
Adobe PDF
|
1.01 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
a-2020_APR_23(3)_1-4_(post-print).pdf
accesso aperto
Tipologia:
2. Post-print / Author's Accepted Manuscript
Licenza:
Pubblico - Tutti i diritti riservati
Dimensione
282.07 kB
Formato
Adobe PDF
|
282.07 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11583/2862674